TRIB - Utang jangka dawa perusahaan trinitybiotech.com

The price chart for Trinity Biotech plc (TRIB) illustrates the dynamics of the company developing diagnostic systems. The business is currently implementing eco-packaging and energy-saving laboratory equipment, while the individual long-term debt metric stands at 0.00. High certification and patent costs for Uni-Gold create a moat against competitors, while the sale of diabetes and HIV tests serves as a steady cash cow.

The investment attractiveness of Trinity Biotech plc depends on the balance between expansion into eco-friendly packaging and its debt load. This indicator captures total liabilities with a maturity of over one year, allowing for an assessment of the business's dependence on borrowed capital and default risks. An analysis of the organization's long-term loans and borrowings reveals the funding pace of energy-efficient developments, determining the sustainability of shareholder value.